Our trustees

Fiona Driscoll

NCRI Chair

Fiona is Chair of the Wessex Academic Health Science Network and Chair of Women on Boards. She is a Non-Executive Director and Audit Chair of UKRI, a Trustee of King Edward VII’s Hospital, a Non-Executive Director of BotOptions (UK) plc and a Member of HM Treasury’s Major Projects Review Panel. Fiona focuses on strategy, through innovation, transformation and commercialisation, and effective governance and risk management, together with the EDI agenda.

Dr Helen Campbell

Helen Campbell is Portfolio Manager for Department of Health Research Networks, Cancer Research, and Clinical Research Facilities. She is based at Exeter University Medical School and works full-time on behalf of the Department of Health. After obtaining a PhD in biochemistry, Helen worked in the medical device and pharmaceutical industry, before taking up post in 1994 as manager of the first NHS National Cancer R&D Programme. Since then, Helen has been involved in every major national development in cancer research in the NHS, including the establishment of the National Cancer Research Network and the National Cancer Research Institute.

Dr Matthew Hobbs

Matthew Hobbs joined Prostate Cancer UK as Deputy Director of Research in 2013, and was appointed as Director of Research in 2020.

Through a period where the charity’s focus has increasingly been placed on funding and translating research that can make a difference for men diagnosed with or at risk of prostate cancer.

Matthew has been responsible for in-year delivery of the charity’s research business plans; has contributed to development of new charity and research strategies; and, with his team, has delivered several targeted research funding schemes and changed how the charity performs horizon scanning, impact assessment, and response mode funding.

Angus McNair

Angus McNair is a NIHR Academic Clinical Lecturer in General Surgery at the University of Bristol and Specialist Registrar in colorectal surgery. He trained in Bristol and the south west of England and completed his doctorate in 2011. His research interests include doctor-patient communication in cancer care, patient and public involvement in research prioritisation and randomised trial methodology.

Cameron Millar

Cameron Millar is a former investment banker and hedge fund manager with a specialisation in foreign exchange derivatives proprietary trading.  He has worked in a variety of locations in senior management roles including London, Frankfurt, Singapore, Tokyo and New York but now lives in Edinburgh.   Cameron has sat on various investment management advisory boards and currently holds a position as Governor (Trustee) at Heriot-Watt University.  In addition, at Heriot Watt, Cameron is Chair of their Donations and Investment Committee, and sits on the Finance Committee and Infrastructure Committee. He is also leading the charge on a fund-raising circle as part of a wider bicentennial appeal. Cameron is a patient advocate for non-smokers lung cancer ALK Positive.

Helen Rowntree

Helen joined Blood Cancer UK in November 2019 as Chief Digital, Services and Innovation Officer and moved to be Director of Research, Services and Engagement in September 2020.

Prior to joining Blood Cancer UK, Helen worked at a senior level in the NHS leading the development of digital services for patients, including nhs.uk. Throughout her career in health, she’s worked to use technology and data to make people’s lives easier and make the complex more simple.

Cathy Scivier

Cathy Scivier was a member of the leadership team at the Institute of Cancer Research (ICR), London for fourteen years, initially as HR Director and latterly as Chief Operating Officer, where a key part of the role was liaison with cancer research funding bodies. Cathy left the ICR in early 2016 to relocate to the north-west of England and now lives in Lancashire. From 2012-2016 she was the ICR’s nominated Governor on the Royal Marsden NHS Foundation Trust’s Governing Body. She has an MSc in HR Management and is a Fellow of the Chartered Institute of Personnel and Development. Prior to joining the ICR she spent over 20 years in healthcare management in the NHS in south west London. She is also a trustee of a number of other charities. She has recently taken on the role of Chair at n-Compass, an advocacy and wellbeing charity. Cathy is also an Independent Member of the Audit Committee of the Greater Manchester Combined Authority.

Dr Ian Walker

Ian was appointed to the Board in 2021 and is responsible for developing and implementing our strategic priorities across policy, information and communications.

Ian has over 15 years of combined experience dedicated to advancements in cancer prevention, diagnosis, and treatment.

First appointed as a CRUK Director in 2013, Ian has held several high impact roles within the charity across basic, translational and clinical research. He brings a wealth of relevant experience to the board, having advised on several of the charity’s key campaigns to inform government policy around the provision of life-saving cancer research, including the push for the protection and restoration of clinical research activity within the NHS during the COVID-19 pandemic.
Ian is a trustee for the Association of Medical Research Charities (AMRC) and has previously held a Non-executive role in the biotechnology sector.
Ian holds a Biochemistry BSc with honours and a PhD from the University of Leeds. He also holds an MBA with distinction from Warwick Business School.